Navigation Links
La doctora Elizabeth H. Blackburn, Premio Nobel, se une al panel del ASTELLAS INNOVATION DEBATE 2013
Date:11/17/2013

mañana. El objetivo del Innovation Debate es airear los temas vitales, desarrollar conclusiones positivas y conseguir el avance de la agenda.

Todo el mundo - profesionales de las ciencias, medicina e industria, y personas en general - tendrán la oportunidad de dirigirse al Astellas Innovation Debate a través de los medios online, haciendo frente a los debates más allá de los muros de la Royal Institution of Great Britain.

El Innovation Debate inaugural de la Royal Society en Londres en noviembre de 2012 se centró en la innovación en un momento de austeridad y nutrición para los innovadores del futuro. Bajo la presidencia del profesor Jim Al-Khalili, reunió a panelistas como el Premio Nobel y profesor Sir Andre Geim, el profesor de Física Brian Cox y la profesora Mariana Mazzucato, profesora de Económicas en la University of Sussex.

Acerca de Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., con sede en el Reino Unido, es una filial europea de Astellas Pharma Inc., una empresa con sede en Tokio. Astellas es una empresa farmacéutica dedicada a mejorar la salud de personas de todo el mundo mediante el suministro de fármacos innovadores y fiables. La compañía tiene como objetivo convertirse en una empresa global que combine capacidades extraordinarias de I+D y marketing y continúe creciendo en el mercado mundial farmacéutico. Astellas Pharma Europe Ltd. es responsable de 21 empresas afiliadas situadas en Europa, Oriente Medio y Africa, la compañía tienen una instalación de I+D y tres plantas de producción en Europa. La compañía cuenta con una plantilla de aproximadamente 4.350
'/>"/>

SOURCE Astellas Pharma Europe Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. New Avenues to Market - Research Report on Isis Pharmaceuticals, Inc., Avon Products, Inc., Elizabeth Arden, Inc., Boyd Gaming Corporation and Ameristar Casinos, Inc.
2. Generex Announces Interview of MD Andersons Dr. Elizabeth Mittendorf, Principal Investigator on Companys AE37 Phase IIb Breast Cancer Efficacy Trial
3. Novo progresso anunciado na ação judicial contra a Assembleia do Prêmio Nobel movida pelo Dr. Rongxiang Xu
4. Exclusive Industry Panel for Medical Device Developers - "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen"
5. Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
6. The Galien Foundation Announces Roster of Luminary Presenters for Third Galien Forum; Program Highlights Include CEO Panel, Panel on Alzheimers Disease Innovation, Nobel Laureate Elie Wiesel
7. BSI to Offer Exclusive Access to Global Panel of Experts in 3 Key Cities
8. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
9. Abaxis Announces the Launch of Kidney Profile Plus Panel
10. Sony Medical Division Teams with Wills Eye Institute to Bring "Expert" Panel of Ophthalmologists to AAO 2012 Convention
11. Varian Medical Systems to Exhibit Flat Panel Detectors, X-Ray Tubes and Imaging Software Optimized for Digital Radiography at MEDICA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... WAYNE, Pa. , July 31, 2015 /PRNewswire/ ... a fully integrated specialty pharmaceutical company focused on ... announced the closing of its previously announced underwritten ... stock at a public offering price of $11.25 ... the offering included 1,000,000 shares issued upon the ...
(Date:7/31/2015)... HYDERABAD, India , July 31, 2015 /PRNewswire/ ... Billing and CRM solutions for video, data and cloud ... (PoC) with a leading pharma giant for Internet ... managing different IoT applications offered on subscription model. ... Pharma giant is striving for business ...
(Date:7/30/2015)... 30, 2015  ResMed Inc. (NYSE: RMD ) ... 2015.  Revenue for the quarter was $453.1 million, a ... 30, 2014 (a 17 percent increase on a constant ... the quarter ended June 30, 2014.  Diluted earnings per ... quarter ended June 30, 2014.  The ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
... ARAY ), the premier radiation oncology company, announced ... UBS Global Life Sciences Conference in New York on Tuesday, ... A live webcast of the presentation will be available ... site at http://www.accuray.com . The webcast replay of the ...
... 16, 2011 The U.S.-Russia Business Council is pleased to ... today to establish two new joint ventures in Russia. These ... fastest-growing markets while enhancing Russia,s power generation and healthcare sectors. ... more than US$10 – 15 billion in sales, GE will ...
Cached Medicine Technology:USRBC President Ed Verona Lauds GE Announcement on Energy and Healthcare Joint Ventures in Russia 2
(Date:8/1/2015)... ... ... Calvary Hospital today announced that it is embarking on a yearlong restoration ... bring this Torah – dating from 1880 – back to kosher status, so that ... Scroll No. 515, from the town of Taus-Domazlice, is on permanent loan to Calvary ...
(Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons of the network ... their Healthy Home mission with the HOPE Movement of EvolvHealth. In what has been ... companies have agreed to join their missions of purpose together to change the course ...
(Date:8/1/2015)... ... August 01, 2015 , ... On Tuesday, July 28th, ... who are thought to have been behind the attack on Anthem Inc. which resulted ... zero day exploits, watering hole attacks and spear phishing campaigns. , For ...
(Date:8/1/2015)... ... 01, 2015 , ... BeverlyD, owner and founder of BeverlyD Luxe Organic Hair ... first small business donation to kick off the campaign for healing and Well-Being. , ... includes a complete line of raw, organic hair care products, as well as her ...
(Date:8/1/2015)... ... ... On March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for Addiction ... stepping off Springer Mountain and heading north. Since that day, Phil has hiked over 1400 ... greeted by friends and family. He visited CCAR and left an inspirational message to ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:March4thforWellBeing Foundation Kickoff 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2
... week's BMJ have their say on whether patients should have ... ,The medical profession is concerned that, in the proposed ... input from the patient, and this is not being made ... Alan Hassey in a letter to this week's journal. ...
... Remedies Ltd today said it has filed its ... fixed dose combination used in the treatment of ... combination, active against multi-resistant strains of both gram- ... coverage of bactericidal activity, it informed the Bombay ...
... journal Substance Abuse Treatment, Prevention and policy unwinds that the ... alcohol dependent patients better for a long term. ... who abstain from drinking alcohol is more than the patients ... at the medical school. Also the abstinence is longer ...
... investigation has revealed that some homeopathic clinics advice people ... of the world.// ,People planning on taking ... avoid homeopathic remedies that are claiming to prevent malaria, ... ,It was reported that every year almost around ...
... Essar group and the Jindal group have committed to ... medicare for people leaving Below Poverty Line in Jharkhand. ... the Sarva Swasthya Mission trust is being formed by ... an official release said here today Independently run by ...
... selected Indian ministry of health and family welfare for ... stance on health promotion and tobacco control"//. ,Minister ... the award at a ceremony during the World Conference ... said. ,The award has been conferred on ...
Cached Medicine News:Health News:Electronic Patient Record "Serious Threat" to Patient Confidentiality 2Health News:Travellers Cautioned Over The Alternate Remedies For Malaria 2
The assay kit is for determination of uric acid in serum or urine. Wavelength: 600 nm. Linear range: up to 80 mg/dL....
Intended for the quantitative determination of uric acid in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 20 mg/dL (1190 mol/L). Single vial, dry powder reagent....
... delivers a new level of immunodiagnostic productivity. ... with any laboratory automation system. No-pause loading ... is the only immunoassay system with this ... system runs without any additional setup. Continuous ...
... A fully automated, random ... over 50 assays available ... tumor marker, therapeutic drug, ... testing can be performed ...
Medicine Products: